In Vivo Glx Measurements From GABA‐Edited HERMES at 3 T Are Not Consistent With Those From Short‐TE PRESS Across Scanners, Brain Regions, Diagnostic and Age Groups
Year: 2025
Type: article
Abstract: 1H-Magnetic resonance spectroscopy (1H-MRS) is a noninvasive technique for quantifying brain metabolites, including glutamate, glutathione (GSH), and γ-aminobutyric acid (GABA), which are essential for brain function and implicated in various neurodevelopmental conditions. As such, 1H-MRS methods that enable reliable and accurate measurement of these metabolites are of considerable clinical value. Hadamard Encoding and Reconstruction of MEGA-Edited Spectroscopy (HERMES; echo time [TE] = 80 ms) is a spectral editing technique that allows for the simultaneous quantification of GABA and GSH, using subtraction approaches to resolve these metabolites in a difference spectrum. Additionally, glutamate plus glutamine resonances (Glx) can be resolved either from the HERMES GABA-edited difference spectrum (GABA-DIFF) or from the sum of all HERMES transients (SUM spectrum). However, the reliability of 80-ms HERMES for quantification of Glx has not been systematically assessed. Here, we evaluate the agreement between Glx obtained from HERMES GABA-DIFF and SUM spectra with Glx derived from short-TE PRESS (TE = 35 ms), which is conventionally used for Glx estimation and has demonstrated reproducibility. Data were acquired from 139 participants across two brain regions (ACC and Thalamus voxels), three scanners, two diagnostic groups (autism and neurotypical development) and two age groups (adolescent/adult and preschooler). Comparisons were made using both creatine-scaled and tissue-corrected Glx estimates. Our findings demonstrate significant systematic and proportional bias between Glx estimates from HERMES (SUM and GABA-DIFF) and short-TE PRESS, consistent across scanners, voxels, age groups and diagnostic categories. These findings indicate that Glx estimates derived from HERMES are not directly comparable to those from short-TE PRESS, and this discrepancy is consistent across a multisite study setting. This underscores the importance of sequence selection and careful methodological consideration when integrating and interpreting data from 1H-MRS across different acquisition protocols.
Source: NMR in Biomedicine
DOI: 10.1002/nbm.70171
Authors: Alice R. Thomson, Viola Hollestein, Amy Goodwin, Anne Fritz, Beth Oakley, Declan Murphy, Edward Bullock, Ellen Demurie, Eva Loth, Giorgia Bussu, Herbert Roeyers, Isabel Yorke, Jan K. Buitelaar, Julia Koziel, Laura Colomar, Manon A. Krol, Matthew Bowdler, Nele Herregods, Pascal Aggensteiner, Pim Pullens, Rosemary Holt, Terje Falck‐Ytter, Tony Charman, Tomoki Arichi, Nicolaas A. Puts
Institutions: King's College London, MRC Centre for Neurodevelopmental Disorders, University of Cambridge, Ghent University, Uppsala University, Radboud University Nijmegen, Radboud University Medical Center, Donders Institute for Brain, Cognition and Behaviour, Ghent University Hospital, Central Institute of Mental Health, Region Stockholm, Karolinska Institutet, Stockholm Health Care Services
Language: English
Subfield: Radiology, Nuclear Medicine and Imaging
Field: Medicine
Domain: Health Sciences
Open Access status: hybrid
Estimated APC paid: $3,640
Funders: Autism Speaks, South London and Maudsley NHS Foundation Trust, European Federation of Pharmaceutical Industries and Associations, Simons Foundation Autism Research Initiative, National Institute for Health and Care Research, King's College London, European Commission, Medical Research Council Centre for Neurodevelopmental Disorders, NIHR Maudsley Biomedical Research Centre, Medical Research Council
Awards: G1114913786, G1307489074, G1498739278, Exploration of cortical structure and function in human infancy with advanced MRI methods, G2624696309, MRC Centre for Neurodevelopmental Disorders, G434337789, G4345436876, G4668817743, G4986414685, G5543596241, G60524263, G6109567720, Autism Innovative Medicine Studies – 2 – Trials, G6733629873, Comorbid Analysis of Neurodevelopmental Disorders and Epilepsy, G8563726104
OpenAlex ID: W4416947659
